Getting From the Bench to the Patient

Sep 27, 2017 by in ONCOLOGY Comments Off on Getting From the Bench to the Patient

Despite significant advances in understanding of molecular pathobiology, the adoption of this knowledge and its application to drug development is sporadic. Consequently, the drug development process has remained intrinsically laborious…

read more

Translational Research in Endocrine Surgery

Sep 27, 2017 by in ONCOLOGY Comments Off on Translational Research in Endocrine Surgery

This article reviews translational research in endocrine surgery, with a focus on disorders of the thyroid, parathyroids, adrenals, and endocrine pancreas. Discovery of genes responsible for heritable endocrine cancer syndromes…

read more

Biomarkers and Targeted Therapeutics in Colorectal Cancer

Sep 27, 2017 by in ONCOLOGY Comments Off on Biomarkers and Targeted Therapeutics in Colorectal Cancer

The development of colorectal cancer is characterized by a multitude of molecular events that can occur through the pathways of loss of heterozygosity, microsatellite instability, and CpG-island methylation. The accumulation…

read more

Targeted Therapy for Cancer

Sep 27, 2017 by in ONCOLOGY Comments Off on Targeted Therapy for Cancer

Gastrointestinal stromal tumors (GISTs) are unique tumors, arising largely due to oncogenic mutations in KIT or PDGFRA tyrosine kinases. Although surgery remains the most effective treatment, the remarkable clinical success…

read more

Translational Research in Melanoma

Sep 27, 2017 by in ONCOLOGY Comments Off on Translational Research in Melanoma

Recent breakthroughs in the fundamental understanding of the cellular and molecular basis of melanoma have culminated in new therapies with unquestionable efficacy. Immunotherapy and targeted therapy strategies have completely transformed…

read more

Cancer Immunotherapy

Sep 27, 2017 by in ONCOLOGY Comments Off on Cancer Immunotherapy

Better understanding of the underlying principles of tumor biology and immunology, enhanced by recent insights into the mechanisms of immune recognition, regulation, and tumor escape has provided new approaches for…

read more

Targeting the p53 Pathway

Sep 27, 2017 by in ONCOLOGY Comments Off on Targeting the p53 Pathway

This article summarizes data on translational studies to target the p53 pathway in cancer. It describes the functions of the p53 and Mdm-2 signaling pathways, and discusses current therapeutic approaches…

read more

Targeting the NF-κB Pathway in Cancer Therapy

Sep 27, 2017 by in ONCOLOGY Comments Off on Targeting the NF-κB Pathway in Cancer Therapy

Most NF-κB inhibitors target the IKK complex, IκB proteins, or NF-κB transcription factors. The most promising classes of inhibitors include antioxidants, antiinflammatory compounds, natural compounds, statins, proteasome inhibitors, IKKβ inhibitors,…

read more

Targeting Receptor Tyrosine Kinases in Solid Tumors

Sep 27, 2017 by in ONCOLOGY Comments Off on Targeting Receptor Tyrosine Kinases in Solid Tumors

Tyrosine kinase (TK) cascades are involved in all stages of tumorigenesis through modulation of transformation and differentiation, cell-cycle progression, and motility. Advances in molecular targeted drug development allow the design…

read more
Get Clinical Tree app for offline access